CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 35 enrolled
Drug / intervention
Breast Cancer Locator Guided Breast Conserving Surgerydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06461663
NCT06461663N/ACompleted

An Interventional, Post-Market Study to Evaluate the Performance of a Custom-made Medical Device, "Breast Cancer Locator (BCL)" System, in Breast-conserving Surgery (BCS)

CairnSurgical, Inc.·interventional·Posted Jun 17, 2024·Updated May 27, 2026

In Brief

A clinical study evaluating Breast Cancer Locator Guided Breast Conserving Surgery for Breast Cancer. Completed, enrolled 35 participants across 6 sites in 3 countries.

Detailed Summary

This interventional, post-market, multicenter clinical investigation is designed to evaluate the performance of a custom-made medical device, "the Breast Cancer Locator (BCL)" in Subjects with non-palpable breast cancer, in Europe.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesGermany, Italy, Switzerland
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedJun 17, 2024
Enrollment StartJun 22, 2022
Primary CompletionApr 19, 2024
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 2.0 years ago

Interventions

Breast Cancer Locator Guided Breast Conserving Surgerydevice

Subjects will undergo a contrast-enhanced supine MRI and two marks will be placed on the breast. The MRI images will be transmitted to the sponsor, and the images will be used to build a BCL using 3D printing. Investigators will be provided with a 3D image of the cancer in the breast. Investigators will use a BCL (a patient-specific, plastic, bra-like form that is placed on the breast and allows the investigator to mark the edges of the tumor on the skin and to place wires inside the breast which define the center of the cancer and the tumor edges. The surgeon will then attempt to surgically remove all the tissue inside the wires used to define the tumor edges.